Condition: Psoriatic Arthritis · Sponsor: Takeda
Psoriatic arthritis (PsA) is a chronic inflammatory disease that affects the joints and skin in people who have psoriasis (PsO). The main aim of the study is to know how well zasocitinib (TAK-279) works in participants with active PsA based on their previous experience with specific treatments. The participants will be treated with either zasocitinib, or placebo. Participants will be in the study for up to 60 weeks.
This description comes directly from the study's public registry record.
Takeda Contact · +1-877-825-3327 · medinfoUS@takeda.com
Always discuss trial participation with your own doctor first.
| Arizona Arthritis & Rheumatology Research, PLLC | Phoenix, AZ | Mesa, Arizona, United States | Recruiting |
| Arizona Arthritis & Rheumatology Research, PLLC | Phoenix, AZ | Phoenix, Arizona, United States | Recruiting |
| Arizona Arthritis & Rheumatology Research, PLLC | Phoenix, AZ | Tucson, Arizona, United States | Recruiting |
| Biovin Enterprises LLC dba Medvin Clinical Research | Covina, CA | Covina, California, United States | Recruiting |
| RASF- Clinical Research Center | Boca Raton, Florida, United States | Recruiting |
| Direct Helpers Medical Center | Hialeah, Florida, United States | Recruiting |
| IRIS Research and Development | Plantation, FL | Plantation, Florida, United States | Recruiting |
| BayCare Medical Group | St. Petersburg, Florida, United States | Recruiting |
| North Georgia Rheumatology Group PC | Lawrenceville, Georgia, United States | Recruiting |
| Clinic of Robert Hozman | Skokie, Illinois, United States | Recruiting |
| Graves Gilbert Clinic | Bowling Green, Kentucky, United States | Recruiting |
| Johns Hopkins Hospital | Baltimore, Maryland, United States | Recruiting |
+ 110 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06671496